Irma Bagdoniene։ Why Intensive Prevention is the Most Rational Strategy in Preventive Cardiology
Irma Bagdoniene, Cardiologist Specializing in Prevention & Lipidology, shared on LinkedIn about a recent article by Jennifer G. Robinson et al, published in Journal of the American Heart Association:
”Is early, intensive prevention ‘aggressive’? It’s not. On World Logic Day, it just makes sense.
I often tell my patients:
The human body follows simple logic.
In preventive cardiology, clinical inertia is a common barrier. But the evidence to avoid delays is overwhelming. This is the basis of our ‘strike early, strike strong’ strategy:
- The logic of time: Atherosclerosis results from cumulative exposure. It’s the total LDL burden over decades—the “mg-years”—that defines risk. The sooner we act, the more years we protect.
- The logic of causality: LDL cholesterol is a proven causal factor in ASCVD. Mendelian randomization studies and large clinical trials consistently confirm this. Lowering LDL prevents downstream events.
- The logic of measurement: We cannot manage what we don’t detect. Risk scores alone fall short. Advanced assessments like CACS, CCTA, Lp(a), and ApoB provide clear evidence of subclinical disease—calling for early intervention.
The conclusion is simple. The evidence and tools are ready. Early application is the most rational approach to stopping heart attacks before they occur.
Prevention is not aggressive—it is the sensible choice.
On World Logic Day (Jan 14), proclaimed by UNESCO, a reminder:
Good medicine is often just good logic!”
Title: Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
Authors: Jennifer G. Robinson, Kevin Jon Williams, Samuel Gidding, Jan Borén, Ira Tabas, Edward A. Fisher, Chris Packard, Michael Pencina, Zahi A. Fayad, Venkatesh Mani, Kerry Anne Rye, Børge G. Nordestgaard, Anne Tybjærg-Hansen, Pamela S. Douglas, Stephen J. Nicholls, Neha Pagidipati, Allan Sniderman
Read the Full Article on Journal of the American Heart Association․
Stay updated on all scientific advances with Hemostasis Today.
-
May 10, 2026, 15:36Manoj Khadka: Omega-3s and Cardiovascular Outcomes in Hemodialysis
-
May 10, 2026, 15:33Abdul Mannan: Here’s when Your POC INR Machine Misleads You
-
May 10, 2026, 15:28Joe Liechty: How It is Essentially Never too Late to Intervene on Chronic Venous Obstructions
-
May 10, 2026, 15:19Islam Arid: Why We Say ‘Time is Brain’ when It’s Coming to Stroke Management?
-
May 10, 2026, 15:14Could You Recognize Thrombotic Thrombocytopenic Purpura (TTP) in Time? – ASH
-
May 10, 2026, 15:13Deepak Lodha: PT and aPTT Mixing Study is a Key Tool in Coagulation Diagnosis
-
May 10, 2026, 15:12Marc Wittwer: Excellent Days at the 7th Coagulation Days in Zagreb
-
May 10, 2026, 15:12Tagreed Alkaltham: WB Donation vs Apheresis Donation – Understanding Donor Reactions and Why They Differ
-
May 10, 2026, 15:11Divyaswathi Citla Sridhar and Leonard Valentino Congratulate Roshni Kulkarni on Her Recognition as Advocate for Women and Girls with Bleeding Disorders